Download Citation
Article Source:
RIPK2 induces docetaxel resistance in prostate cancer through the NF-κB/P-gp signaling pathway
Xing S,
Xu Z,
Zeng S,
Yue M,
Xing W,
et al.
(2026)
RIPK2 induces docetaxel resistance in prostate cancer through the NF-κB/P-gp signaling pathway.
PLOS ONE 21(1): e0341445.
https://doi.org/10.1371/journal.pone.0341445